Original Article

Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey
  • Vahit Özmen
  • Ajlan Atasoy
  • Erhan Gökmen
  • Mustafa Özdoğan
  • Nilufer Güler
  • Cihan Uras
  • Engin Ok
  • Orhan Demircan
  • Abdurrahman Işıkkdoğan
  • Neslihan Cabioğlu
  • Fatma Şen
  • Pınar Saip
Eur J Breast Health 2016; 12: 107-111 DOI: 10.5152/tjbh.2016.2874
The Correlation of Magee EquationsTM and Oncotype DX® Recurrence Score From Core Needle Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in ER+ and HER2- Breast Cancer
  • Atilla Soran
  • Kaori Tane
  • Efe Sezgin
  • Rohit Bhargava
Eur J Breast Health 2020; 16: 117-123 DOI: 10.5152/ejbh.2020.5338
Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female Controls
  • Joseph Liu
  • Anupama Suresh
  • Marilly Palettas
  • Julie Stephens
  • Akaansha Ganju
  • Evan Morgan
  • Mahmoud Kassem
  • Yanjun Hou
  • Anil Parwani
  • Anne Noonan
  • Raquel Reinbolt
  • Jeffrey VanDeusen
  • Sagar Sardesai
  • Nicole Williams
  • Mathew Cherian
  • Gary Tozbikian
  • Daniel G. Stover
  • Maryam Lustberg
  • Zaibo Li
  • Bhuvaneswari Ramaswamy
  • Robert Wesolowski
Eur J Breast Health 2020; 16: 201-207 DOI: 10.5152/ejbh.2020.5536
Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization
  • Çağlar Ünal
  • Tolga Özmen
  • Çetin Ordu
  • Cihan Uras
  • Halil Kara
  • Erhan Gökmen
  • Mustafa Özdoğan
  • Orhan Demircan
  • Kezban Nur Pilancı
  • Tomris Duymaz
  • Vahit Özmen
Eur J Breast Health 2023; 19: 325-330 DOI: 10.4274/ejbh.galenos.2023.2023-8-5 PMID:37795003